The association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men

Cancer Genetics and Cytogenetics

Volumn 190, Issue 2, 2009, Pages 88-92

  Song, Jaemann ^a   Kim, Duk Yoon ^b   Kim, Choung Soo ^c   Kim, Hyung Jin ^d   Lee, Dong Hyeon ^e   Lee, Hyun Moo ^f   Ko, Woojin ^g   Lee, Gilho ^h  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Catholic University of Daegu   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d Chonbuk National University Medical School   (South Korea)

^e Ewha Womans University School of Medicine   (South Korea)

^f Sungkyunkwan University School of Medicine   (South Korea)

^g Yonsei University   (South Korea)

^h Dankook University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 4;

AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; HUMANS; KOREA; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK FACTORS; TOLL-LIKE RECEPTOR 4;

EID: 64549116737     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.12.011     Document Type: Article

References (18)

1. Smith D.S., Bullock A.D., Catalona W.J., and Herschman J.D. Racial differences in a prostate cancer screening study. J Urol 156 (1996) 1366-1369
2. Hsing A.W., Tsao L., and Devesa S.S. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 85 (2000) 60-67
3. Haas G.P., and Sakr W.A. Epidemiology of prostate cancer. CA Cancer J Clin 47 (1997) 273-287
4. Kim W.J., Chung J.I., Hong J.H., Kim C.S., Jung S.I., and Yoon D.K. Epidemiological study for urologic cancer in Korea (1998-2002). Korean J Urol 45 (2004) 1081-1088
5. Nelson K.A., and Witte J.S. Androgen receptor CAG repeats and prostate cancer. Am J Epidemiol 155 (2002) 883-890
6. Binnie M.C., Alexander F.E., Heald C., and Habib F.K. Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer. Prostate 63 (2005) 309-315
7. Means T.K., Golenblock D.T., and Fenton M.J. The biology of Toll-like receptors. Cytokine Growth Factor Rev 11 (2000) 219-232
8. Beutler B. Endotoxin, Toll-like receptor 4, and the afferent limb of innate immunity. Curr Opin Microbiol 3 (2000) 23-28
9. Zheng S.L., Augustsson-Bälter K., Chang B., Hedelin M., Li L., Adami H.O., Bensen J., Li G., Johnasson J.E., Turner A.R., Adams T.S., Meyers D.A., Isaacs W.B., Xu J., and Grönberg H. Sequence variants of Toll-like receptor 4 are associated with prostate cancer risk: results from the Cancer Prostate in Sweden Study. Cancer Res 64 (2004) 2918-2922
10. Cheng I., Plummer S.J., Casey G., and Witte J.S. Toll-like receptor 4 genetic variation and advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev 16 (2007) 352-355
11. Chen Y.-C., Giovannucci E., Lazarus R., Kraft P., Ketkar S., and Hunter D.J. Sequence variants of prostate cancer. Cancer Res 65 (2005) 11771-11778
12. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., and Lee S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat Res (2001) 480-481 243-268
13. Roberts R.O., Bergstralh E.J., Bass S.E., Lieber M.M., and Jacobsen S.J. Prostatitis as a risk factor for prostate cancer. Epidemiology 15 (2004) 93-99
14. Rosenblatt K.A., Wicklund K.G., and Stanford J.L. Sexual factors and the risk of prostate cancer. Am J Epidemiol 152 (2000) 1152-1158
15. Dennis L.K., Lynch C.F., and Torner J.C. Epidemiologic association between prostatitis and prostate cancer. Urology 60 (2002) 78-83
16. Nickel J.C., and Xiang J. Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis. J Urol 179 (2008) 1391-1395
17. Michel O., LeVan T.D., Stern D., Dentener M., Thorn J., Gnat D., Beijer M.L., Cochaux P., Holt P.G., Martinez F.D., and Rylander R. Systemic responsiveness to lipopolysaccharide and polymorphisms in the Toll-like receptor 4 gene in human beings. J Allergy Clin Immunol 112 (2003) 923-929
18. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in. Tlr4 gene. Science 282 (1998) 2085-2088